全文获取类型
| 收费全文 | 217747篇 |
| 免费 | 3616篇 |
| 国内免费 | 302篇 |
专业分类
| 耳鼻咽喉 | 1626篇 |
| 儿科学 | 7590篇 |
| 妇产科学 | 3686篇 |
| 基础医学 | 21852篇 |
| 口腔科学 | 3264篇 |
| 临床医学 | 15771篇 |
| 内科学 | 42046篇 |
| 皮肤病学 | 1234篇 |
| 神经病学 | 20784篇 |
| 特种医学 | 10662篇 |
| 外科学 | 35124篇 |
| 综合类 | 2428篇 |
| 一般理论 | 7篇 |
| 预防医学 | 19847篇 |
| 眼科学 | 3360篇 |
| 药学 | 11901篇 |
| 中国医学 | 711篇 |
| 肿瘤学 | 19772篇 |
出版年
| 2023年 | 380篇 |
| 2022年 | 620篇 |
| 2021年 | 1475篇 |
| 2020年 | 882篇 |
| 2019年 | 1220篇 |
| 2018年 | 23101篇 |
| 2017年 | 18322篇 |
| 2016年 | 20518篇 |
| 2015年 | 2212篇 |
| 2014年 | 2552篇 |
| 2013年 | 2924篇 |
| 2012年 | 10219篇 |
| 2011年 | 24137篇 |
| 2010年 | 20509篇 |
| 2009年 | 13091篇 |
| 2008年 | 21975篇 |
| 2007年 | 24317篇 |
| 2006年 | 3028篇 |
| 2005年 | 4450篇 |
| 2004年 | 5410篇 |
| 2003年 | 6211篇 |
| 2002年 | 4160篇 |
| 2001年 | 906篇 |
| 2000年 | 1033篇 |
| 1999年 | 804篇 |
| 1998年 | 565篇 |
| 1997年 | 496篇 |
| 1996年 | 341篇 |
| 1995年 | 318篇 |
| 1994年 | 302篇 |
| 1993年 | 237篇 |
| 1992年 | 422篇 |
| 1991年 | 433篇 |
| 1990年 | 465篇 |
| 1989年 | 375篇 |
| 1988年 | 322篇 |
| 1987年 | 261篇 |
| 1986年 | 247篇 |
| 1985年 | 296篇 |
| 1984年 | 188篇 |
| 1983年 | 159篇 |
| 1982年 | 137篇 |
| 1980年 | 105篇 |
| 1979年 | 150篇 |
| 1978年 | 76篇 |
| 1977年 | 81篇 |
| 1976年 | 75篇 |
| 1975年 | 75篇 |
| 1974年 | 87篇 |
| 1973年 | 88篇 |
排序方式： 共有10000条查询结果，搜索用时 15 毫秒
31.
Alessandro Abbouda Paolo Tortorella Lucia Restivo Elisa Santoro Federica De Marco Maurizio La Cava 《Seminars in ophthalmology》2016,31(6):532-541
Purpose: To evaluate the rate and onset of intraoperative and postoperative complications post-phacoemulsification. Methods: One hundred sixty-two eyes of 145 patients with uveitis who underwent phacoemulsification between 2006 and 2009 were identified through surgical record review. Fifty-nine eyes of 46 patients met the inclusion criteria. Hazard ratio (HR) and Kaplan-Meier survival probability were calculated for each class of uveitis. Results: Macular edema (ME) resulted to be associated to chronic postoperative inflammation (r?=?0.6; p?=?0.00) and mostly related to patients who presented more than one postoperative relapse/year (r?=?0.2; p?=?0.02). Fuchs uveitis resulted to be a risk factor for posterior capsule opacification (PCO) (HR 3.36 IC95%1.0-10.5; p?=?0.03). Hypotony and elevated intraocular pressure (IOP) were detected in the anterior uveitis group (0.02 EY). Conclusion: The HR to develop ME was significantly related to chronic anterior uveitis. PCO and elevated IOP are most frequent in Fuchs uveitis. The postoperative visual acuity result was good among all the uveitis groups. 相似文献
32.
33.
34.
35.
Umar Nadia K. Badshah Maaz B. Sandrasegaran Kumar Ghabril Marwan Agarwal Saurabh Tann Mark Lacerda Marco Kwo Paul Y. 《Digestive diseases and sciences》2015,60(7):2196-2200
Digestive Diseases and Sciences - To determine whether the presence of portal vein thrombosis (PVT) where venous flow within the liver may be altered may delay the diagnosis of HCC and be... 相似文献
36.
Marco Maruzzo Umberto Basso Eugenio Borsatti Laura Evangelista Filippo Alongi Orazio Caffo Francesca Maines Sara Galuppo Rocco De Vivo Fable Zustovich Dario Palleschi Andrea Zivi Teodoro Sava Mariella Sorarù Roberto Iacovelli Maurizio Nicodemo Susanne Baier Lucia Fratino Vittorina Zagonel 《Clinical genitourinary cancer》2019,17(1):e187-e194
Background
Radium 223 was introduced for metastatic castration-resistant prostate cancer based on the results of a randomized controlled trial showing risk reduction for death and skeletal events. Our aim was to evaluate the outcome of patients receiving radium 223 in a real-world setting.Patients and Methods
We conducted a multicenter retrospective analysis in the Triveneto region of Italy.Results
One hundred fifty-eight patients received radium 223 in our region. After a median follow-up of 9.5 months, 75 patients died. The median overall survival (OS) was 14.2 months, and the median progression-free survival (PFS) was 6.2 months. Seventy-one (45%) patients achieved progression as best response. Thirty-seven (23%) patients stopped the treatment early because of progression. Eastern Cooperative Oncology Group performance status was prognostic for OS (18.4 vs. 12.3 vs. 7.5 months; 0 vs. 1, P = .0062; 0 vs. 2, P = .0002), whereas previous prostatectomy or docetaxel exposure were not. A neutrophil to lymphocytes ratio ≥ 3 significantly impacted OS (18.1 vs. 9.7 months; P < .001) and slightly impacted PFS (6.6 vs. 5.6 months; P = .05). Patients with a baseline alkaline phosphatase (ALP) value ≥ 220 U/L had worse OS and PFS (24.1 vs. 10.5 months; 7.2 vs. 5.5 months; P < .001). Patients with changes in ALP value achieved better OS (P = .029) and PFS (P = .002). There was no difference according to the line of therapy (0 vs. ≥ 1; P = .490). The main grade 3/4 toxicities were anemia, asthenia, and thrombocytopenia.Conclusion
This large real-world report confirms comparable OS and PFS data when compared with the pivotal study, as well as the predictive role of ALP and neutrophil to lymphocytes ratio. The definition of the optimal position of radium 223 in the treatment of metastatic castration-resistant prostate cancer has still to be defined. 相似文献37.
Giorgio Gandaglia Guillaume Ploussard Massimo Valerio Agostino Mattei Cristian Fiori Nicola Fossati Armando Stabile Jean-Baptiste Beauval Bernard Malavaud Mathieu Roumiguié Daniele Robesti Paolo Dell’Oglio Marco Moschini Stefania Zamboni Arnas Rakauskas Francesco De Cobelli Francesco Porpiglia Francesco Montorsi Alberto Briganti 《European urology》2019,75(3):506-514
Background
Available models for predicting lymph node invasion (LNI) in prostate cancer (PCa) patients undergoing radical prostatectomy (RP) might not be applicable to men diagnosed via magnetic resonance imaging (MRI)-targeted biopsies.Objective
To assess the accuracy of available tools to predict LNI and to develop a novel model for men diagnosed via MRI-targeted biopsies.Design, setting, and participants
A total of 497 patients diagnosed via MRI-targeted biopsies and treated with RP and extended pelvic lymph node dissection (ePLND) at five institutions were retrospectively identified.Outcome measurements and statistical analyses
Three available models predicting LNI were evaluated using the area under the receiver operating characteristic curve (AUC), calibration plots, and decision curve analyses. A nomogram predicting LNI was developed and internally validated.Results and limitations
Overall, 62 patients (12.5%) had LNI. The median number of nodes removed was 15. The AUC for the Briganti 2012, Briganti 2017, and MSKCC nomograms was 82%, 82%, and 81%, respectively, and their calibration characteristics were suboptimal. A model including PSA, clinical stage and maximum diameter of the index lesion on multiparametric MRI (mpMRI), grade group on targeted biopsy, and the presence of clinically significant PCa on concomitant systematic biopsy had an AUC of 86% and represented the basis for a coefficient-based nomogram. This tool exhibited a higher AUC and higher net benefit compared to available models developed using standard biopsies. Using a cutoff of 7%, 244 ePLNDs (57%) would be spared and a lower number of LNIs would be missed compared to available nomograms (1.6% vs 4.6% vs 4.5% vs 4.2% for the new nomogram vs Briganti 2012 vs Briganti 2017 vs MSKCC).Conclusions
Available models predicting LNI are characterized by suboptimal accuracy and clinical net benefit for patients diagnosed via MRI-targeted biopsies. A novel nomogram including mpMRI and MRI-targeted biopsy data should be used to identify candidates for ePLND in this setting.Patient summary
We developed the first nomogram to predict lymph node invasion (LNI) in prostate cancer patients diagnosed via magnetic resonance imaging-targeted biopsy undergoing radical prostatectomy. Adoption of this model to identify candidates for extended pelvic lymph node dissection could avoid up to 60% of these procedures at the cost of missing only 1.6% patients with LNI. 相似文献38.
39.
40.
